Abstract | BACKGROUND: Mycoplasma bovis is a worldwide pathogen, causative agent of pneumonia, mastitis, arthritis, and a variety of other symptoms in cattle. The economic losses due to mycoplasma pneumonia could be reduced by antibiotic treatment. The aim of the present study was to determine the in vitro susceptibility of M. bovis strains isolated from cattle in Hungary to eleven antibiotics. RESULTS: CONCLUSIONS: Our results emphasize the necessity of periodic testing for antibiotic susceptibility in this geographic region. Based on our in vitro examinations, fluoroquinolones could be the most effective drugs for the therapy of M. bovis infections in Hungary. However, current antimicrobial use policies have to be taken into account to avoid further antibiotic resistance development and to reserve fluoroquinolones for the treatment of severe infections which have responded poorly to other classes of antimicrobials.
|
Authors | Kinga M Sulyok, Zsuzsa Kreizinger, Lilla Fekete, Veronika Hrivnák, Tibor Magyar, Szilárd Jánosi, Nóra Schweitzer, Ibolya Turcsányi, László Makrai, Károly Erdélyi, Miklós Gyuranecz |
Journal | BMC veterinary research
(BMC Vet Res)
Vol. 10
Pg. 256
(Oct 25 2014)
ISSN: 1746-6148 [Electronic] England |
PMID | 25344297
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
|
Topics |
- Animals
- Anti-Bacterial Agents
(pharmacology)
- Cattle
- Cattle Diseases
(epidemiology, microbiology)
- Drug Resistance, Bacterial
- Hungary
(epidemiology)
- Microbial Sensitivity Tests
- Mycoplasma Infections
(microbiology, veterinary)
- Mycoplasma bovis
(drug effects, isolation & purification)
|